Bioprinting is a powerful technology in tissue and organ fabrication which has gained significant interest in medicine, biotech and pharmaceutics.
regenHU dedicates its engineering efforts on supporting the scientific community with cutting-edge bioprinting and biofabrication solutions to enable scientific advancements leading to the development of novel clinical products, therapies and solutions.
To date our bioprinting solutions are used for multidisciplinary applications, among other:
- Tissue engineering
- Regenerative & Personalized medicine
- Drug Screening & Development
- Fundamental Science to understand cell-cell/morphogens interactions and responses
- Functional Food
- Microfluidics, Lab & Organ-on-a-chip
- Academic Research & Education
- We will be delighted on supporting your activity with our expertise, passion & network.
FREIGEIST FELLOWSHIP SUPPORTS DR. IVAN MINEV IN USING 3D PRINTING TO FIND WAYS TO REPAIR DAMAGE IN THE HUMAN BODY
"Dr. Ivan Minev, research group leader at the BIOTEC/CRTD, has been awarded a Freigeist Fellowship from the VolkswagenStiftung. ..." >> Read the complete article.Read more
"The University of Virginia has acquired two new state-of-the-art three-dimensional bioprinters and has begun training lab scientists and bioengineers to “print” tissues that could eventually be used to treat patients with illnesses and injuries ranging from burns to diabetes, and heart, liver and kidney failure.Read more
BIOPRINTER AT UVA DESIGNED TO PRINT HUMAN TISSUE
"Der Schweizer Pharmariese Novartis setzt bei der Medikamentenentwicklung auf einen 3D-Biodrucker. Die Technologie könnte die Anzahl Tierversuche künftig verringern.Read more
UTRECHT, 8 July 2016 -- Partnering experts in 3D bioprinting with experts in biomanufacturing has resulted in the first melt electrospinning device that incorporates the use of bio-inks. Housed at the Utrecht Biofabrication Facility, this combination of techniques may lead to improved and more accurate 3D bioprinting for therapeutic use.Read more